|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/06 | |
| A61K 31/55 | |||
| A61P 35/00 | |||
| A61K 31/551 | |||
| A61P 29/00 | |||
| A61P 37/00 | |||
| C07D 487/16 |
| (11) | Patento numeris | 3315500 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17183473.2 |
| Europos patento paraiškos padavimo data | 2011-12-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (72) |
ZHOU, Changyou, US
REN, Bo, CN
WANG, Hexiang, CN
|
| (73) |
BeiGene, Ltd.,
Mourant Ozannes, Corporate Services (Cayman) Limited, Harbour Centre 42 North Church Street PO box 1348, Grand Cayman KY1-1108,
KY
|
| (54) | FUSED TETRA OR PENTA-CYCLIC DIHYDRODIAZEPINOCARBAZOLONES AS PARP INHIBITORS |
| FUSED TETRA OR PENTA-CYCLIC DIHYDRODIAZEPINOCARBAZOLONES AS PARP INHIBITORS |